Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects
| author | |
| created | [InstanceEdit:9724683] Jassal, Bijay, 2021-03-25 |
| dbId | 9724679 |
| displayName | Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects |
| journal | Clin. Exp. Allergy |
| pages | 1371-85 |
| pubMedIdentifier | 25200415 |
| schemaClass | LiteratureReference |
| title | Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects |
| url | http://www.ncbi.nlm.nih.gov/pubmed/25200415 |
| volume | 44 |
| year | 2014 |
Referrals
| (literatureReference) | |
| (author) |
© 2026 Reactome
